Real-World study tracks Apalutamide's impact on prostate cancer patients
NCT ID NCT06019676
First seen Nov 01, 2025 · Last updated May 03, 2026 · Updated 26 times
Summary
This study follows 170 men with metastatic hormone-sensitive prostate cancer who choose to take apalutamide as part of their standard care. Researchers will measure how well the drug lowers PSA levels and how it affects fatigue, thinking skills, and overall quality of life using questionnaires over two years. The goal is to see if results from controlled trials hold true in real-world settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust
Cambridge, CB2 0QQ, United Kingdom
-
Buckinghamshire Healthcare NHS Trust
Aylesbury, HP21 8AL, United Kingdom
-
Clatterbrdige Cancer Centre, NHS Foundation Trust
Liverpool, CH63 4JY, United Kingdom
-
East Lancashire Hospitals NHS Trust
Blackburn, BB2 3HH, United Kingdom
-
Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust
Newcastle, NE7 7DN, United Kingdom
-
Northern Ireland Cancer Centre, Belfast Health & Social Care Trust
Belfast, BT9 7AB, United Kingdom
-
South Tyneside and Sunderland NHS Foundation Trust
Newcastle, NE34 0PL, United Kingdom
-
The James Cook University Hospital, South Tees Hospitals NHS Foundation Trust
Middlesbrough, TS4 3BW, United Kingdom
-
The Royal Marsden Hospital
Sutton, Surrey, SM2 5PT, United Kingdom
-
The University Hospital of North Tees
Stockton-on-Tees, TS19 8PE, United Kingdom
-
University Hospitals of Morecambe Bay NHS Foundation Trust
Lancaster, LA1 4RP, United Kingdom
-
Velindre Cancer Centre, Velindre University NHS Trust
Cardiff, CF14 2TL, United Kingdom
Conditions
Explore the condition pages connected to this study.